Crossmark

Controversy of tissue-agnostic approvals in immunotherapy and targeted therapy

Crossref DOI link: https://doi.org/10.1007/s12032-022-01672-5

Published Online: 2022-04-28

Published Print: 2022-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bose, Chinmoy K. https://orcid.org/0000-0002-5416-0945
License Information

Text and Data Mining valid from 2022-04-28

Version of Record valid from 2022-04-28
More Information

Article History

Received: 12 January 2022

Accepted: 28 January 2022

First Online: 28 April 2022

Declarations

:

: The authors have not disclosed any conflict of interest.